The study concluded as compared with an insulin pump, a wearable, automated, bihormonal, bionic pancreas improved mean glycemic levels, with less frequent hypoglycemic episodes, among both adults and adolescents with type 1 diabetes mellitus.

Read more at:

Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes — NEJM.